It demonstrated a link to survival and overall clinical outcomes by stratifying samples according to the genetic alteration status of three distinct cancer drivers found commonly in colorectal cancer KRAS, GNAS, and TP53 [34]. Here, TP53 is linked to colorectal cancer.